Abstract |
Alcaligenes are opportunistic commensal bacteria that reside in gut-associated lymphoid tissues such as Peyer's patches (PPs); however, how they create and maintain their homeostatic environment, without inducing an excessive inflammatory response remained unclear. We show here that Alcaligenes-derived lipopolysaccharide (Alcaligenes LPS) acts as a weak agonist of toll-like receptor 4 and promotes IL-6 production from dendritic cells, which consequently enhances IgA production. The inflammatory activity of Alcaligenes LPS was weaker than that of Escherichia coli-derived LPS and therefore no excessive inflammation was induced by Alcaligenes LPS in vitro or in vivo. Alcaligenes LPS also showed adjuvanticity, inducing antigen-specific immune responses without excessive inflammation. These findings reveal the presence of commensal bacteria-mediated homeostatic inflammatory conditions within PPs that produce optimal IgA induction without causing pathogenic inflammation and suggest that Alcaligenes LPS could be a safe and potent adjuvant.
|
Authors | Naoko Shibata, Jun Kunisawa, Koji Hosomi, Yukari Fujimoto, Keisuke Mizote, Naohiro Kitayama, Atsushi Shimoyama, Hitomi Mimuro, Shintaro Sato, Natsuko Kishishita, Ken J Ishii, Koichi Fukase, Hiroshi Kiyono |
Journal | Mucosal immunology
(Mucosal Immunol)
Vol. 11
Issue 3
Pg. 693-702
(05 2018)
ISSN: 1935-3456 [Electronic] United States |
PMID | 29411777
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adjuvants, Immunologic
- Immunoglobulin A
- Interleukin-6
- Lipopolysaccharides
- Tlr4 protein, mouse
- Toll-Like Receptor 4
|
Topics |
- Adjuvants, Immunologic
- Alcaligenes
(immunology)
- Animals
- Antibody Formation
- Cells, Cultured
- Dendritic Cells
(immunology)
- Gram-Negative Bacterial Infections
(immunology)
- Homeostasis
- Immunoglobulin A
(metabolism)
- Inflammation
(immunology)
- Interleukin-6
(metabolism)
- Lipopolysaccharides
(immunology)
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, Transgenic
- Toll-Like Receptor 4
(agonists)
|